Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients

Karyopharm Therapeutics Inc · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
myelodysplastic syndrome, kpt-330, karyopharm, selinexor, sier, myelodysplastic syndrome (mds), erythropoietin (epo), refractory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 853129
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.